Video Experimental Relacionado
Updated: Jul 20, 2026
09:18
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
El inhibidor natural del factor de crecimiento transformador beta protege contra la cicatrización en la enfermedad
W A Border1, N A Noble, T Yamamoto
1Division of Nephrology, University of Utah School of Medicine, Salt Lake City 84132.
Nature
|November 26, 1992
Resumen
La administración de Decorin reduce efectivamente la acumulación de la matriz extracelular en la enfermedad renal experimental al neutralizar el factor de crecimiento transformador-beta (TGF-beta). Este hallazgo sugiere que el decorin
Área de la Ciencia:
- Nefrología Nefrología.
- Patología Patología Patología.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La insuficiencia renal se caracteriza por la acumulación de matriz extracelular en los glomérulos.
- La sobreexpresión del factor de crecimiento transformador-beta (TGF-beta) impulsa la acumulación de la matriz patológica en la glomerulonefritis experimental.
Objetivo del estudio:
- Investigar el potencial de la decorina para antagonizar la actividad del TGF-beta in vivo.
- Para evaluar la eficacia terapéutica de la decorina en un modelo experimental de glomerulonefritis.
Principales métodos:
- Administración de decorina a ratas con glomerulonefritis experimental.
- Evaluación de la producción de la matriz glomerular y las manifestaciones de la enfermedad.
Principales resultados:
- La administración de Decorin inhibió el aumento de la producción de la matriz extracelular.
- El tratamiento con Decorin atenuó las manifestaciones clínicas de la enfermedad renal experimental.
Conclusiones:
- Decorin actúa como un regulador natural de TGF-beta, inhibiendo sus efectos patológicos.
- Decorin se muestra prometedor como una terapia clínica potencial para las enfermedades renales asociadas con TGF-beta.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:50Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...